GRETCHEN CASPER: Open Payments
NPI 1285092569 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 9 payments from 7 companies in 2025. Trend: 2023 $166 · 2024 $213 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $60 |
| Invivyd Inc | 1 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Amgen Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: TARPEYO, PEMGARDA, PURIFIED CORTROPHIN GEL, Kerendia, TAVNEOS, FABRAZYME, JYNARQUE.
Industry payments across MO — which companies pay providers there.
